Systems Approach to Immunity and Inflammation
免疫和炎症的系统方法
基本信息
- 批准号:10291571
- 负责人:
- 金额:$ 188.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-11-24 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:Antiviral ResponseArchitectureBioinformaticsC-Type LectinsCellsCollaborationsCommunicable DiseasesCommunitiesComplexComputer AnalysisDataDiseaseGene ProteinsGenesGenomicsGoalsHost DefenseHumanImmuneImmune responseImmune signalingImmune systemImmunityImmunologic ReceptorsIndividualInfectionInflammationInflammatoryInfluenzaInformaticsInnate Immune ResponseInterferon Type IInterferonsInvadedKnowledgeLaboratoriesLigandsLinkMediatingMolecularMultiplexed Ion Beam ImagingMusMutant Strains MiceOrthologous GeneOutputPathogenesisPathway interactionsPattern recognition receptorPharmaceutical PreparationsProteomicsReagentReceptor SignalingRegulationRegulator GenesResourcesRoleSignal PathwaySignal TransductionStreptococcus pneumoniaeSystemSystems BiologyToll-like receptorsUrsidae FamilyVaccine DesignWorkcombatdata managementepigenomicsforward geneticsgenetic approachhuman diseaseimmunoregulationin vivoinnate immune functionlarge scale datamacrophagemembermicroorganismmolecular phenotypenew technologynovel strategiespathogenphenotypic dataprogram disseminationprogramsreceptorresponsesingle cell analysissuperinfectiontooltranscriptomics
项目摘要
Summary
The innate immune response is a double-edged sword; it is absolutely required for host defense, but
unregulated, causes inflammatory disease. Diverse and potent mechanisms have evolved to recognize and
counter invading microorganisms. These include a variety of pattern recognition receptors, including Toll-like
receptors (TLRs), RIG-I-like receptors (RLRs), Nod-like receptors (NLRs) and C-type lectin like receptors
(CLRs) that recognize conserved molecular motifs on pathogens. While significant progress has been made in
identifying the ligands detected by these receptors and the signaling cascades that they activate, a number of
critical questions regarding the mechanisms that appropriately tailor the outputs of these pathways remain
unanswered.
Furthermore, the immune response to live pathogens is shaped by the interaction of multiple receptors and
their cognate signaling pathways. The aggregate response is complex and cannot be predicted from analysis
of each pathway in isolation; however, it is tractable using the tools of systems biology and forward genetics.
Over the past 15 years members of this U19 consortium have collaborated using cross-disciplinary approaches
to define the molecular mechanisms underlying the regulation of immune receptors and pathways. Their
genetic approaches have also linked the pathways to pathogenesis and to immunity in vivo. These studies
have also generated a significant body of work demonstrating cross-regulation between innate immune
receptors.
This U19 consists of two interrelated Projects that probe the innate immune response to infection. In Project 1,
the Beutler laboratory will work in close collaboration with the Aderem, Nolan, and Ulevitch laboratories, taking
a highly automated forward genetic approach to the analysis of innate immune signaling. In Project 2, the
Aderem laboratory will determine mechanisms by which the TLR and type I interferon pathways cross-regulate
each other. The Projects will be supported by three scientific Cores: The Signaling Core, will bring to bear
several novel technologies for highly multiplexed molecular phenotyping of immune cells. The Data
Management and Bioinformatics Core will support the individual Projects as well as the overall goals of the
program through integrated computational analysis of all large-scale datasets. The Human Correlation Core
will examine the relevance of mouse genes, demonstrated in Projects 1 and 2 to mediate innate immune
functions, in the analogous human pathways.
概括
先天免疫反应是一把双刃剑。这对于宿主防御来说是绝对必要的,但是
不受调节,导致炎症性疾病。已经发展出多种有效的机制来识别和
对抗入侵的微生物。其中包括多种模式识别受体,包括 Toll 样受体
受体 (TLR)、RIG-I 样受体 (RLR)、Nod 样受体 (NLR) 和 C 型凝集素样受体
(CLR)识别病原体上的保守分子基序。虽然已经取得了重大进展
识别这些受体检测到的配体以及它们激活的信号级联,许多
关于适当调整这些途径的输出的机制的关键问题仍然存在
无人回答。
此外,对活病原体的免疫反应是由多种受体和
他们的同源信号通路。总体响应很复杂,无法通过分析进行预测
每个路径都是孤立的;然而,使用系统生物学和正向遗传学工具可以轻松处理它。
在过去 15 年里,这个 U19 联盟的成员使用跨学科方法进行合作
定义免疫受体和途径调节的分子机制。他们的
遗传方法还将这些途径与发病机制和体内免疫联系起来。这些研究
还开展了大量工作,证明先天免疫之间的交叉调节
受体。
该 U19 由两个相互关联的项目组成,旨在探索对感染的先天免疫反应。在项目1中,
Beutler 实验室将与 Aderem、Nolan 和 Ulevitch 实验室密切合作,
用于分析先天免疫信号的高度自动化的正向遗传方法。在项目2中,
Aderem 实验室将确定 TLR 和 I 型干扰素途径交叉调节的机制
彼此。这些项目将得到三个科学核心的支持:信号核心,将发挥作用
几种用于免疫细胞高度多重分子表型分析的新技术。数据
管理和生物信息学核心将支持各个项目以及项目的总体目标
通过对所有大规模数据集的综合计算分析来编程。人类关联核心
将检查项目 1 和 2 中演示的小鼠基因与介导先天免疫的相关性
功能,在类似的人类途径中。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard J Ulevitch其他文献
Richard J Ulevitch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard J Ulevitch', 18)}}的其他基金
相似国自然基金
“共享建筑学”的时空要素及表达体系研究
- 批准号:
- 批准年份:2019
- 资助金额:63 万元
- 项目类别:面上项目
基于城市空间日常效率的普通建筑更新设计策略研究
- 批准号:51778419
- 批准年份:2017
- 资助金额:61.0 万元
- 项目类别:面上项目
宜居环境的整体建筑学研究
- 批准号:51278108
- 批准年份:2012
- 资助金额:68.0 万元
- 项目类别:面上项目
The formation and evolution of planetary systems in dense star clusters
- 批准号:11043007
- 批准年份:2010
- 资助金额:10.0 万元
- 项目类别:专项基金项目
新型钒氧化物纳米组装结构在智能节能领域的应用
- 批准号:20801051
- 批准年份:2008
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms of viral RNA maturation by co-opting cellular exonucleases
通过选择细胞核酸外切酶使病毒 RNA 成熟的机制
- 批准号:
10814079 - 财政年份:2023
- 资助金额:
$ 188.73万 - 项目类别:
Mechanisms of viral RNA maturation by co-opting cellular exonucleases
通过选择细胞核酸外切酶使病毒 RNA 成熟的机制
- 批准号:
10463469 - 财政年份:2022
- 资助金额:
$ 188.73万 - 项目类别:
Lung-on-a-Chip Disease Models for Efficacy Testing
用于功效测试的芯片肺疾病模型
- 批准号:
10228594 - 财政年份:2017
- 资助金额:
$ 188.73万 - 项目类别: